PubRank

Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial. (DIP)

Clinical Trial ID NCT01991197

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01991197

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008 38.76
2 C-reactive protein: a critical update. J Clin Invest 2003 11.77
3 Psoriasis. N Engl J Med 2009 8.80
4 Psoriasis. N Engl J Med 2005 8.56
5 Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis. N Engl J Med 2010 2.74
6 Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. N Engl J Med 2003 2.12
7 Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits. Diabetes Care 2010 1.91
8 Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis. Diabetologia 2011 1.76
9 Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes. BMC Endocr Disord 2010 1.60
10 Dipeptidyl peptidase-4 inhibitors and bone fractures: a meta-analysis of randomized clinical trials. Diabetes Care 2011 1.58
11 Sitagliptin reduces albuminuria in patients with type 2 diabetes. Endocr J 2010 1.10
12 Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients. Metabolism 2009 1.04
13 C-reactive protein and alpha2-macroglobulin plasma activity in medium-severe and severe psoriasis. J Eur Acad Dermatol Venereol 2004 1.01
14 Sitagliptin, a dipeptidyl peptidase-IV inhibitor, improves psoriasis. Dermatology 2011 1.00
15 Gastric bypass surgery improves psoriasis. J Am Acad Dermatol 2010 0.94
16 Dipeptidyl peptidase in autoimmune pathophysiology. Adv Clin Chem 2011 0.93
17 Efficacy and safety of combination Acitretin and Pioglitazone therapy in patients with moderate to severe chronic plaque-type psoriasis: a randomized, double-blind, placebo-controlled clinical trial. Arch Dermatol 2009 0.91
18 Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study. J Eur Acad Dermatol Venereol 2012 0.84
19 Keratinocytes express dipeptidyl-peptidase IV (CD26) in benign and malignant skin diseases. Br J Dermatol 1996 0.82
20 Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation. J Invest Dermatol 2006 0.82
21 C-reactive protein and markers for thrombophilia in patients with chronic plaque psoriasis. Int J Immunopathol Pharmacol 2011 0.78
22 CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes. Br J Dermatol 2008 0.78
23 High-sensitivity C-reactive protein in psoriasis. Int J Dermatol 2011 0.75
Next 100